Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | CTSD | P07339 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3134710 | 0.89 | ALDH1A1 (0.57) | ALDH1A1LMNASMN1; SMN2TSHRCTSD | |
| SCHEMBL7055735 | 0.78 | CES2 (0.54) | ALDH1A1LMNASMN1; SMN2KMT2ACYP1A2 | |
| SCHEMBL1418030 | 0.78 | CES2 (0.54) | ALDH1A1LMNASMN1; SMN2KMT2ACYP1A2 | |
| SCHEMBL30893562 | 0.75 | TSHR (0.68) | ALDH1A1GPR35TSHRCTSDKMT2A | |
| SCHEMBL3671 | 0.75 | TSHR (0.68) | ALDH1A1GPR35TSHRCTSDKMT2A | |
| SCHEMBL6226801 | 0.74 | GPR35 (0.42) | ALDH1A1GPR35TSHRCYP1A2 | |
| Potassium Ion SCHEMBL16267317 | 0.73 | TSHR (0.66) | ALDH1A1GPR35TSHRCTSDKMT2A | |
| SCHEMBL10824707 | 0.73 | TSHR (0.66) | ALDH1A1GPR35TSHRCTSDKMT2A | |
| SCHEMBL16267318 | 0.73 | TSHR (0.66) | ALDH1A1GPR35TSHRCTSDKMT2A | |
| SCHEMBL7791983 | 0.73 | TSHR (0.66) | ALDH1A1GPR35TSHRCTSDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5091 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3169430-B1 | NEW ULTRAHIGH EFFICIENCY, SUPERFICIALLY POROUS PARTICLE (SPP) CHIRAL PHASES FOR LIQUID CHROMATOGRAPHY | AZYP LLC (US) | 2021-11-10 | — | — | EP | claimed |
| US-10272364-B2 | Superficially porous particle (SPP) chiral phases for liquid chromatography | AZYP, LLC (US) | 2019-04-30 | — | — | US | claimed |
| US-20170197156-A1 | NEW ULTRAHIGH EFFICIENCY, SUPERFICIALLY POROUS PARTICLE (SPP) CHIRAL PHASES FOR LIQUID CHROMATOGRAPHY | AZYP, LLC (US) | 2017-07-13 | — | — | US | claimed |
| EP-3169430-A1 | NEW ULTRAHIGH EFFICIENCY, SUPERFICIALLY POROUS PARTICLE (SPP) CHIRAL PHASES FOR LIQUID CHROMATOGRAPHY | Azyp LLC (US) | 2017-05-24 | — | — | EP | claimed |
| WO-2016011425-A1 | NEW ULTRAHIGH EFFICIENCY, SUPERFICIALLY POROUS PARTICLE (SPP) CHIRAL PHASES FOR LIQUID CHROMATOGRAPHY | AZYP, LLC (US) | 2016-01-21 | — | — | WO | claimed |
| EP-1149099-A2 | IMIDAZO[4,5-C]-PYRIDINE-4-ON-DERIVATIVES | MERCK PATENT GmbH (DE) | 2001-10-31 | — | — | EP | claimed |
| WO-2000040583-A2 | IMIDAZO[4,5-C]-PYRIDINE-4-ON-DERIVATIVES | MERCK PATENT GMBH (DE) | 2000-07-13 | — | — | WO | claimed |
| US-5786428-A | POLYMER MATRIX OF UNSATURATED MONOMER AND METAL COMPLEX HAVING A LIGAND AND A POLYMERIZABLE UNSATURATED MOIETY; EFFICIENT, RAPID AND SIMPLE PURIFICATION; MEDICAL DIAGNOSIS; | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1998-07-28 | — | — | US | claimed |
| US-6432953-B1 | — | — | None | — | — | US | disclosed |
| CN-122094690-A | Pharmaceutical composition comprising Maraglinib (MARALIXIBAT) and use thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122071439-A | Benzo-ring-containing compounds as protein tyrosine phosphatase inhibitors and uses thereof | 湖北生物医药产业技术研究院有限公司 | 2026-05-22 | — | — | CN | disclosed |
| WO-2026103853-A1 | TSHR ANTAGONIST COMPOUND, PHARMACEUTICAL COMPOSITION, METHOD FOR PREPARING SAME, AND USE THEREOF | 长春金赛药业有限责任公司 | 2026-05-21 | — | — | WO | disclosed |
| WO-2026103887-A1 | PROLINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | 北京康辰药业股份有限公司 | 2026-05-21 | — | — | WO | disclosed |
| CN-122070482-A | Methods of using neurofilament light chain immunoassays | 美国西门子医学诊断股份有限公司 | 2026-05-19 | — | — | CN | disclosed |
| EP-0301402-A1 | Leukotriene antagonists, process for their preparation and their use in the treatment of illnesses | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-02-01 | — | — | EP | disclosed |
| EP-0299558-A1 | Process for the preparation of ibuprofen | GIST-BROCADES N.V. (NL) | 1989-01-18 | — | — | EP | disclosed |
| EP-0299559-A1 | Process for the preparation of 2-aryloxypropionic acids | GIST-BROCADES N.V. (NL) | 1989-01-18 | — | — | EP | disclosed |
| US-4788199-A | ANXIOLYTICS, ANTICONVULSANTS, ANTIANGINA AGENTS | RHONE-POULENC SANTE (FR) | 1988-11-29 | — | — | US | disclosed |
| US-4788204-A | TRANQUILIZERS; ANTICONVULSANTS; ANGINA AND IMMUNODIFICIENCY TREATMENTS | RHONE-POULENC SANTE (FR) | 1988-11-29 | — | — | US | disclosed |
| EP-0210084-A1 | Amides, processes for their preparation and medicaments containing them | RHONE-POULENC SANTE (FR) | 1987-01-28 | — | — | EP | disclosed |